Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Ibrutinib for Steroid Refractory Chronic Graft Vs Host Disease - Real World Experience

Gaurav Sutrave, Tishya Indran, Yatika Jivan, Andrew Hutchison, Nada Hamad, Sui Tan, Duncan Purtill, Andrew Grigg, Siok-Keen Tey, David J. Curtis, David J Gottlieb, Abir Bhattacharyya

Blood (2022) 140 (Supplement 1): 10537–10539.

https://doi.org/10.1182/blood-2022-168683

Published: 2022

Journal Articles

Bone Mineral Densitometry Diagnostic Yield Remains High Beyond 10 Years Post Allogeneic Stem Cell Transplant

Megan Hogg, Jacinta Perram, Abir Bhattacharyya, Ian Bilmon, Emily Blyth, John Kwan, Kenneth P. Micklethwaite, Shyam Panicker, Amanda Seabrook, David J Gottlieb

Blood (2022) 140 (Supplement 1): 7680–7681.

https://doi.org/10.1182/blood-2022-159843

Published: 2022

Journal Articles

Novel Antigens LMA and Kma Are Expressed on Malignant Bone Marrow Plasma Cells from Patients with Relapsed Refractory Multiple Myeloma and Plasma Cell Dyscrasias

Mary Sartor, David J Gottlieb, Rosanne Dunn

Blood (2022) 140 (Supplement 1): 4211–4212.

https://doi.org/10.1182/blood-2022-167427

Published: 2022

Journal Articles

Third-Party Partially HLA Matched Fungus-Specific T-Cells (FSTs) Used to Treat Invasive Fungal Infection (IFI) with Scedosporium Aurantiacum after Allogeneic Hemopoietic Stem Cell Transplant (aHSCT)

Shafqat Inam, Gaurav Sutrave, Selmir Avdic, Janine Street, Elissa Atkins, Leighton Edward Clancy, David J Gottlieb

Blood (2021) 138 (Supplement 1): 2825.

https://doi.org/10.1182/blood-2021-152384

Published: 2021

Journal Articles

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry

Edward Abadir, Jad Othman, John Kwan, David J Gottlieb, Glen A Kennedy, Ashish Bajel, Richard Doocey, Travis Perera, Anne-Marie Watson, Peter G Bardy, Matthew Greenwood, David J. Curtis, Steven Tran, John Moore, Nada Hamad

Blood (2021) 138 (Supplement 1): 2929.

https://doi.org/10.1182/blood-2021-149939

Published: 2021

Journal Articles

A Novel B Cell Antigen Designated Lambda Myeloma Antigen (LMA) Has Been Identified Using Two Fully Human Monoclonal Antibodies (Mabs) That Bind to Similar Epitopes on Plasma Cells from Patients with Plasma Cell Dyscrasias

Mary Sartor, Daniel Y Hu, Thomas X Lemarchand, Luise Britz, Rosanne Dunn, David J Gottlieb

Blood (2021) 138 (Supplement 1): 1595.

https://doi.org/10.1182/blood-2021-148243

Published: 2021

Journal Articles

Early Administration of Partially HLA Matched Third Party Virus-Specific T-Cells in Conjunction with Antiviral Treatment for Initial Viral Infection after Allogeneic Stem Cell Transplant Is Safe and Leads to High Rates of Viral Control

Wei Jiang, Gaurav Sutrave, Selmir Avdic, Leighton Edward Clancy, Shafqat Inam, Elissa Atkins, Caroline M Bateman, Adrian Gabriel Selim, Vicki Antonenas, Janine Street, Renee Simms, Peter J. Shaw, David Ritchie, Emily Blyth, David J Gottlieb

Blood (2021) 138 (Supplement 1): 255.

https://doi.org/10.1182/blood-2021-152396

Published: 2021

Journal Articles

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac -modified CD19 CAR T cells

Blood (2021) 138 (16): 1504–1509.

https://doi.org/10.1182/blood.2021010813

Published: 2021

Includes: Supplemental data

Journal Articles

Investigation of product-derived lymphoma following infusion of piggyBac -modified CD19 chimeric antigen receptor T cells

Blood (2021) 138 (16): 1391–1405.

https://doi.org/10.1182/blood.2021010858

Published: 2021

Includes: Supplemental data

Journal Articles

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Emily Blyth, Leighton Clancy, Renee Simms, Chun K. K. Ma, Jane Burgess, Shivashni Deo, Karen Byth, Ming-Celine Dubosq, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb

Blood (2013) 121 (18): 3745–3758.

https://doi.org/10.1182/blood-2012-08-448977

Published: 2013

Journal Articles

T time for transplants

David J. Gottlieb

Blood (2010) 116 (22): 4391–4393.

https://doi.org/10.1182/blood-2010-09-305177

Published: 2010

Journal Articles

Epstein-Barr Virus Specific Cytotoxic T Cells for Clinical Use in Immune Reconstitution Post Haemopoietic Stem Cell Transplant.

Emily Blyth, B., Med, (Hons), FRACP, FRCPA, Leighton E Clancy, Upinder Sandher, Rajiv Khanna, BSc, MSc, PhD, David J Gottlieb

Blood (2009) 114 (22): 2435.

https://doi.org/10.1182/blood.V114.22.2435.2435

Published: 2009

Journal Articles

BK Virus Specific Cytotoxic T Cells Expanded for Clinical Use Exhibit Multiple Cytokine Functions and Individual Variation in Antigen Specificity.

Emily Blyth, Leighton E Clancy, Upinder Sandher, David J Gottlieb

Blood (2009) 114 (22): 2437.

https://doi.org/10.1182/blood.V114.22.2437.2437

Published: 2009

Journal Articles

CCR5 Expression On Circulating Blood DC Post-Allogeneic Hemopoietic Cell Transplant Is Highly Predictive for the Development of Clinically Significant Acute Graft Versus Host Disease.

Mary M Sartor, BSc, MSc, Jenny Lau, BSc, hons, David J Gottlieb, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA

Blood (2009) 114 (22): 2251.

https://doi.org/10.1182/blood.V114.22.2251.2251

Published: 2009

Journal Articles

Factors Predicting the Outcome of the Blood and Marrow Transplant Patients Admitted to Intensive Care Unit.

Nalini K Pati, Biju George, Ian Kerridge, Nicole Gilroy, Vineet Nayyar, Eddie Stachowski, Mary McGurgan, Gillian Huang, Kenneth F Bradstock, David J Gottlieb, Mark Hertzberg

Blood (2009) 114 (22): 3340.

https://doi.org/10.1182/blood.V114.22.3340.3340

Published: 2009

Journal Articles

The role of the human cytomegalovirus UL111A gene in down-regulating CD4 + T-cell recognition of latently infected cells: implications for virus elimination during latency

Allen K. L. Cheung, David J. Gottlieb, Bodo Plachter, Sandra Pepperl-Klindworth, Selmir Avdic, Anthony L. Cunningham, Allison Abendroth, Barry Slobedman

Blood (2009) 114 (19): 4128–4137.

https://doi.org/10.1182/blood-2008-12-197111

Published: 2009

Journal Articles

Increased Expression of PD-1 on CD4 + T Cells from Patients with Chronic Lymphocytic Leukemia

Mary M Sartor, BSc, MSc, David J Gottlieb, MD, FRACP, FRCPA

Blood (2008) 112 (11): 4154.

https://doi.org/10.1182/blood.V112.11.4154.4154

Published: 2008

Journal Articles

Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts

Nalini K Pati, MBBS, MD, DNB, Frances Garvin, BSc, Vicki Antonenas, BSc, Ian Kerridge, FRACP, FRCPA, PhD, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, David J Gottlieb, MD, FRACP, FRCPA

Blood (2008) 112 (11): 3468.

https://doi.org/10.1182/blood.V112.11.3468.3468

Published: 2008

Journal Articles

Use of Reduced Intensity Conditioning (RIC) Regimens Are Associated with a Better Outcome with Sibling Donors Transplants in Older Patients (> 50 years) with Acute Myeloid Leukemia (AML)

Biju George, Ian Kerridge, Gillian Huang, David J Gottlieb, Mark Hertzberg, Ken Bradstock

Blood (2008) 112 (11): 3307.

https://doi.org/10.1182/blood.V112.11.3307.3307

Published: 2008

Journal Articles

CMV Specific T Cells for Adoptive Transfer Exhibit Multiple Effector Functions Associated with Protective Immunity Including the Concurrent Production of Cytokines and Cytolytic Activity

Leighton E Clancy, Kenneth P Micklethwaite, Emily Blyth, Upinder Sandher, David J Gottlieb, MD, FRACP, FRCPA

Blood (2008) 112 (11): 3481.

https://doi.org/10.1182/blood.V112.11.3481.3481

Published: 2008

NARROW

Ibrutinib for Steroid Refractory Chronic Graft Vs Host Disease - Real World Experience

Bone Mineral Densitometry Diagnostic Yield Remains High Beyond 10 Years Post Allogeneic Stem Cell Transplant

Novel Antigens LMA and Kma Are Expressed on Malignant Bone Marrow Plasma Cells from Patients with Relapsed Refractory Multiple Myeloma and Plasma Cell Dyscrasias

Third-Party Partially HLA Matched Fungus-Specific T-Cells (FSTs) Used to Treat Invasive Fungal Infection (IFI) with Scedosporium Aurantiacum after Allogeneic Hemopoietic Stem Cell Transplant (aHSCT)

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry

A Novel B Cell Antigen Designated Lambda Myeloma Antigen (LMA) Has Been Identified Using Two Fully Human Monoclonal Antibodies (Mabs) That Bind to Similar Epitopes on Plasma Cells from Patients with Plasma Cell Dyscrasias

Early Administration of Partially HLA Matched Third Party Virus-Specific T-Cells in Conjunction with Antiviral Treatment for Initial Viral Infection after Allogeneic Stem Cell Transplant Is Safe and Leads to High Rates of Viral Control

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac -modified CD19 CAR T cells

Investigation of product-derived lymphoma following infusion of piggyBac -modified CD19 chimeric antigen receptor T cells

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

T time for transplants

Epstein-Barr Virus Specific Cytotoxic T Cells for Clinical Use in Immune Reconstitution Post Haemopoietic Stem Cell Transplant.

BK Virus Specific Cytotoxic T Cells Expanded for Clinical Use Exhibit Multiple Cytokine Functions and Individual Variation in Antigen Specificity.

CCR5 Expression On Circulating Blood DC Post-Allogeneic Hemopoietic Cell Transplant Is Highly Predictive for the Development of Clinically Significant Acute Graft Versus Host Disease.

Factors Predicting the Outcome of the Blood and Marrow Transplant Patients Admitted to Intensive Care Unit.

The role of the human cytomegalovirus UL111A gene in down-regulating CD4 + T-cell recognition of latently infected cells: implications for virus elimination during latency

Increased Expression of PD-1 on CD4 + T Cells from Patients with Chronic Lymphocytic Leukemia

Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts

Use of Reduced Intensity Conditioning (RIC) Regimens Are Associated with a Better Outcome with Sibling Donors Transplants in Older Patients (> 50 years) with Acute Myeloid Leukemia (AML)

CMV Specific T Cells for Adoptive Transfer Exhibit Multiple Effector Functions Associated with Protective Immunity Including the Concurrent Production of Cytokines and Cytolytic Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only